MAPT and Alzheimer disease: Lower levels of Aβ42 and higher levels of T-tau are found in cerebrospinal fluid of AD subjects leading to a lower Aβ42/T-tau ratio in AD compared with cognitively healthy (CH) study participants (Blennow et al., 2001; Harrington et al., 2013).